Speyside Health is the healthcare consulting practice of Speyside Group: a senior-led advisory firm helping pharmaceutical and biotech companies succeed in complex, international markets. A central core team leads every engagement, integrating medical affairs, policy and government affairs, communications and market access, and works through a strong local footprint in 40+ countries to turn strategy into real, measurable change for clients on the ground.
Countries with local teams
Years of healthcare expertise
Capability pillars, integrated or standalone
APAC · Europe Middle East · Africa · LATAM
Speyside Health has local teams across more than 40 countries, organised in five regional platforms:
In CEE since the mid-1990s; operational across 19 countries spanning the EU5, CEE, Russia and Eurasia.
Regional hubs in India and Singapore, with team members on the ground in fifteen countries from China to Australia.
Offices in Brazil, Mexico and Colombia, supported by consultants and affiliates across Central & South America and the Caribbean.
Led from Saudi Arabia with capability across all GCC markets, serving public and private sector clients.
Overseen from hub offices in South Africa, Kenya and Nigeria, with reach across the continent.
Senior people, named and accountable, clients work with the people on this page, supported by an extended network of vetted in-market consultants and key experts across 40+ countries.
CEO & Head of Healthcare. Over the last 25 years Ian has led international policy programs for many leading healthcare multinationals. During this time, he has lived, built and managed teams across Central & Eastern Europe, Latin America and Asia Pacific. In recent years he has focused on global & regional counsel to set policy strategy and frameworks.
Deputy Head of Healthcare, Medical Affairs Director. Connects stakeholder-specific streams into a strategic thread that drives change in clinical practice. Joined from IQVIA, where she led the Medical Affairs Communications Practice.
LATAM Healthcare Practice Lead. Medical doctor and clinical epidemiologist with over 12 years of experience in health policy and healthcare strategy across Latin America.
Senior Consultant, Healthcare Practice. Public policy specialist with 5+ years across ASEAN, leading health-policy projects and advocacy for multinational clients.
We work across the therapeutic landscape, with documented depth in the areas below. Each groups the specific conditions our teams have delivered on:
Rare diseases, spinal muscular atrophy (SMA) and gene therapies, pulmonary arterial hypertension (PAH), haemophilia.
Oncology, lung, breast, prostate, melanoma, hepatocellular carcinoma (HCC / liver), and cell & gene therapies.
Immunology.
Non-communicable diseases, cardiovascular disease and lipid management, ischemic stroke, diabetes and cardiorenal, chronic kidney disease (CKD), COPD and respiratory.
Women's health, maternal and neonatal health.
Infectious diseases, HIV & viral hepatitis, vaccines (RSV, COVID-19).
Consumer health, self-care / OTC.
Nutrition, clinical nutrition.
Diagnostics & MedTech.
@speyside-group.com